Guided Therapeutics (GTHP) Return on Sales Growth (3y) (2013 - 2026)
Guided Therapeutics (GTHP) Return on Sales Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 0.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 0.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 0.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 0.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 0.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 0.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 0.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 0.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 0.00 |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | 31.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.00 |
| Dec 31, 2025 | 332.00 |
| Sep 30, 2025 | 355.00 |
| Jun 30, 2025 | 178.00 |
| Mar 31, 2025 | -2,341.00 |
| Dec 31, 2024 | -645.00 |
| Sep 30, 2024 | -60.00 |
| Jun 30, 2024 | 460.00 |
| Mar 31, 2024 | -32.00 |
| Dec 31, 2023 | -99.00 |
| Sep 30, 2023 | -95.00 |
| Jun 30, 2023 | 145.00 |
| Mar 31, 2023 | -96.00 |
| Dec 31, 2022 | -402.00 |
| Sep 30, 2022 | -241.00 |
| Jun 30, 2022 | 2,478.00 |
| Mar 31, 2022 | -89.00 |
| Dec 31, 2021 | 58.00 |
| Sep 30, 2021 | 377.00 |
| Jun 30, 2021 | -944.00 |